DCPH - Deciphera Pharmaceuticals GAAP EPS of -$0.60 misses by $0.04 revenue of $36.35M beats by $0.47M
- Deciphera Pharmaceuticals press release ( NASDAQ: DCPH ): Q4 GAAP EPS of -$0.60 misses by $0.04 .
- Revenue of $36.35M (+50.2% Y/Y) beats by $0.47M .
- Generated Gross Proceeds of Approximately $143.7 Million from Public Offering in January 2023
For further details see:
Deciphera Pharmaceuticals GAAP EPS of -$0.60 misses by $0.04, revenue of $36.35M beats by $0.47M